{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:05:12Z","timestamp":1788786312977,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020732","name":"Innovative Research Team of High-level Local University in Shanghai","doi-asserted-by":"publisher","award":["SHSMU-ZDCX20211901"],"award-info":[{"award-number":["SHSMU-ZDCX20211901"]}],"id":[{"id":"10.13039\/100020732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jneuroim.2023.578245","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T01:50:24Z","timestamp":1700531424000},"page":"578245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Drug-drug interaction between paxlovid and tacrolimus in a patient with myasthenia gravis and SARS-CoV-2 infection"],"prefix":"10.1016","volume":"385","author":[{"given":"Ying","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangtai","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2023.578245_bb0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cpt.113","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 Genotype and Tacrolimus Dosing","volume":"98","author":"Birdwell","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0010","doi-asserted-by":"crossref","first-page":"1226647","DOI":"10.3389\/fphar.2023.1226647","article-title":"The effect of tacrolimus conversion from immediate- to extended-release formulation on renal function in renal transplant patients: a meta-analysis","volume":"14","author":"Chao","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/1756285615571873","article-title":"The emerging role of tacrolimus in myasthenia gravis","volume":"8","author":"Cruz","year":"2015","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0020","series-title":"medRxiv\u202f: The Preprint Server for Health Sciences","article-title":"Nirmatrelvir plus ritonavir for early COVID-19 and hospitalization in a large US health system","author":"Dryden-Peterson","year":"2022"},{"key":"10.1016\/j.jneuroim.2023.578245_bb0025","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/bcp.14585","article-title":"Monitoring the tacrolimus concentration in peripheral blood mononuclear cells of kidney transplant recipients","volume":"87","author":"Francke","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0030","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1600-6143.2004.00383.x","article-title":"Pharmacokinetics of tacrolimus in kidney transplant recipients: twice daily versus once daily dosing","volume":"4","author":"Hardinger","year":"2004","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0040","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1074\/jbc.RA119.007928","article-title":"Active-site differences between substrate-free and ritonavir-bound cytochrome P450 (CYP) 3A5 reveal plasticity differences between CYP3A5 and CYP3A4","volume":"294","author":"Hsu","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0045","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3349\/ymj.2019.60.7.633","article-title":"Long-Term Safety and Efficacy of Tacrolimus in Myasthenia Gravis","volume":"60","author":"Kim","year":"2019","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101907","article-title":"Tacrolimus is effective for neuromyelitis optica spectrum disorders with or without anti-AQP4 antibody","volume":"39","author":"Kojima","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0055","doi-asserted-by":"crossref","first-page":"768","DOI":"10.23876\/j.krcp.22.218","article-title":"Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir\/ritonavir) administration in a kidney transplant recipient","volume":"41","author":"Kwon","year":"2022","journal-title":"Kidney Rese. Clin. Pract."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/FPC.0000000000000472","article-title":"Composite CYP3A phenotypes influence tacrolimus dose-adjusted concentration in lung transplant recipients","volume":"32","author":"Liu","year":"2022","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.jneuroim.2023.578245_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.transproceed.2023.07.007","article-title":"Effect of Paxlovid on Tacrolimus Concentration in Perioperative Kidney Transplant patients Infected with COVID-19: a Case Report","author":"Liu","year":"2023","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0070","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2174\/1389200218666170531112038","article-title":"Differential Regulation of CYP3A4 and CYP3A5 and its Implication in Drug Discovery","volume":"18","author":"Lolodi","year":"2017","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0075","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/WCO.0000000000000596","article-title":"Myasthenia gravis: from autoantibodies to therapy","volume":"31","author":"Mantegazza","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0080","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7341493","article-title":"Paxlovid: mechanism of action, synthesis, and in silico study","volume":"2022","author":"Marzi","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0085","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/cpt.2646","article-title":"Recommendations for the Management of Drug-Drug Interactions between the COVID-19 Antiviral Nirmatrelvir\/Ritonavir (Paxlovid) and Comedications","volume":"112","author":"Marzolini","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0090","article-title":"Paxlovid-induced tacrolimus toxicity in the treatment of COVID-19: a case report","volume":"15","author":"Michael","year":"2023","journal-title":"Cureus."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/cen3.12739","article-title":"The Japanese clinical guidelines 2022 for myasthenia gravis and Lambert\u2013Eaton myasthenic syndrome","volume":"14","author":"Murai","year":"2023","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0100","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciac443","article-title":"Effectiveness of Paxlovid in reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk patients","volume":"76","author":"Najjar-Debbiny","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0105","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","article-title":"International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update","volume":"96","author":"Narayanaswami","year":"2021","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0110","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.2147\/NDT.S319500","article-title":"Clinical evaluation of the efficacy and safety of co-administration of wuzhi capsule and tacrolimus in adult Chinese patients with myasthenia gravis","volume":"17","author":"Peng","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0115","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.transproceed.2022.04.015","article-title":"Paxlovid (Nirmatelvir\/Ritonavir) and tacrolimus drug-drug interaction in a kidney transplant patient with SARS-2-CoV infection: a case report","volume":"54","author":"Prikis","year":"2022","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0120","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/cpt.2563","article-title":"PharmVar GeneFocus: CYP3A5","volume":"112","author":"Rodriguez-Antona","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0125","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1053\/j.ajkd.2015.10.024","article-title":"Novel Once-daily extended-release tacrolimus versus twice-daily tacrolimus in de novo kidney transplant recipients: two-year results of phase 3, double-blind, randomized trial","volume":"67","author":"Rostaing","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0130","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: Executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/phar.2480","article-title":"Tacrolimus intrapatient variability in solid organ transplantation: a multiorgan perspective","volume":"41","author":"Schumacher","year":"2021","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0140","article-title":"Paxlovid with caution: Novel Case of Paxlovid-Induced Tacrolimus Toxicity in a Cardiac Transplant Patient","volume":"9","author":"Shah","year":"2022","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13181-022-00922-2","article-title":"Tacrolimus Drug-Drug Interaction with Nirmatrelvir\/Ritonavir (PaxlovidTM) managed with Phenytoin","volume":"19","author":"Sindelar","year":"2023","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0150","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S1473-3099(22)00430-3","article-title":"Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection","volume":"22","author":"Sun","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jneuroim.2023.578245_bb0155","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00467-022-05712-0","article-title":"Elevated tacrolimus levels after treatment with nirmatrelvir\/ritonavir (Paxlovid) for COVID-19 infection in a child with a kidney transplant","volume":"38","author":"Young","year":"2023","journal-title":"Pediatr. Nephrol. (Berlin, Germany)"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557282300231X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557282300231X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T19:58:01Z","timestamp":1736366281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557282300231X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":31,"alternative-id":["S016557282300231X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578245","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-drug interaction between paxlovid and tacrolimus in a patient with myasthenia gravis and SARS-CoV-2 infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"578245"}}